hope they will shine some positive light on the new instrument tomorrow. other than that, it's all up to the big boys. It may still tank momentarily, but still believe the bigger surprise is to the up side
this is bad news for those who are seeking for a quick gains, but good news for those with the eye on longer horizon. SBIR is the longer route but to a much bigger bang compares to immediate partnership. Using SBIR money to develop pipelines to Phase I may be II, then seek for partner.
agreed, just take an iron stomach. Started 3.39 this time around and I am still a buyer. I think NSPH this time is an easy one. One month till report, just keep buying..GLTA
that's why we got a 5 penny boost instead, you are right this is one step forward toward a real clinical trial. What's significant is that this is the first study as DRUG, with these results, getting a P1 approval is just a matter of logistics. Hope it close 1.7
closing above 1.7 set the stage for the firework
with the way the two business is structured, is this a possibility..I am just thinking loud different ways leading to the bank..
when was the last time NAVB had pre-mkt trading? and it's happening on this day of presentation at JPM, and BIND is making the JV a big deal, mentioning it all over the places..
looks like yesterday's move set off some triggers, both buyers and penny profit takers. A mil share only pushed up 2 cents. Let's have some more volume next week...
The general market is too rich in valuation, time for money to rotate into the under valued issues.